Venkata Subramanian Krishnaraju

Norwegian Womens Public Health Association, Post Graduate Institute of Medical Education and Research

Papers

Total Citations

H-Index

About

Venkata Subramanian Krishnaraju is a pioneering nuclear medicine researcher whose work bridges advanced molecular imaging and interventional precision. His primary research areas include prostate cancer diagnostics, PET/CT-guided biopsy techniques, and targeted therapeutic interventions for musculoskeletal pain. Krishnaraju’s most impactful contribution is his landmark 2022 study on 68Ga-PSMA PET/CT-guided robotic-assisted transgluteal prostatic biopsy, which demonstrated a novel approach to overcoming the limitations of conventional transrectal ultrasound-guided biopsy. This work, cited 38 times, has significantly improved the diagnostic yield for prostate cancer by enabling precise targeting of PSMA-avid lesions, reducing false negatives and unnecessary repeat procedures. His ongoing phase 2 trial on [18F]NaF PET/CT-guided intraarticular blocks for lumbar facet and sacroiliac joint arthropathy, though early in citation impact, represents a groundbreaking fusion of diagnostic imaging and therapeutic intervention, offering a paradigm shift in managing chronic spinal pain. Krishnaraju’s work is characterized by its translational focus—taking cutting-edge PET tracers from the lab to the clinic—and his publications consistently push the boundaries of image-guided therapy. For students and researchers, his career exemplifies how molecular imaging can be harnessed to solve real-world diagnostic and therapeutic challenges, making him a key figure in the evolution of precision medicine.